What is the price-to-earnings ratio of Cytogen?
The price-earnings ratio of Cytogen is currently -19.68.
Cytogen P/E 2025
Cytogen P/E
-19.68
Ticker
217330.KQ
ISIN
KR7217330000
As of Jan 19, 2025, Cytogen's P/E ratio was -19.68, a 6.15% change from the -18.54 P/E ratio recorded in the previous year.
The Cytogen P/E history
Cytogen Aktienanalyse
What does Cytogen do?
Cytogen ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Cytogen's P/E Ratio
The Price to Earnings (P/E) Ratio of Cytogen is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Cytogen's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Cytogen is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Cytogen’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Cytogen stock
How has the price-earnings ratio of Cytogen changed compared to last year?
The price-to-earnings ratio of Cytogen has increased by 6.15% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Cytogen high compared to other companies?
Yes, the price-to-earnings ratio of Cytogen is high compared to other companies.
How does an increase in the price-earnings ratio of Cytogen affect the company?
An increase in the price-earnings ratio of Cytogen would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Cytogen affect the company?
A decrease in the price-earnings ratio of Cytogen would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Cytogen?
Some factors that influence the price-earnings ratio of Cytogen are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Cytogen pay?
Over the past 12 months, Cytogen paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cytogen is expected to pay a dividend of 0 KRW.
What is the dividend yield of Cytogen?
The current dividend yield of Cytogen is .
When does Cytogen pay dividends?
Cytogen pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Cytogen?
Cytogen paid dividends every year for the past 0 years.
What is the dividend of Cytogen?
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
In which sector is Cytogen located?
Cytogen is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cytogen kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cytogen from 1/19/2025 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 1/19/2025.
When did Cytogen pay the last dividend?
The last dividend was paid out on 1/19/2025.
What was the dividend of Cytogen in the year 2024?
In the year 2024, Cytogen distributed 0 KRW as dividends.
In which currency does Cytogen pay out the dividend?
The dividends of Cytogen are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cytogen
Our stock analysis for Cytogen Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cytogen Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.